Brightsurf Science News & Current Events

December 05, 2009
Advances in diagnosing and treating leukemia and myeloproliferative disorders
Leukemia and myeloproliferative disorders are serious and often deadly blood cancers.

Drug shows promise for T315I-mutated chronic myeloid leukemia
Omacetaxine shows activity against chronic myeloid leukemia with T315I mutation, M.D.

New gene findings will help guide treatment in infant leukemia
Pediatric oncologists have identified specific genes, dubbed partner genes, that fuse with another gene to drive an often-fatal form of leukemia in infants.

Multiple myeloma patients experience high response rate with new 3-drug combination
A new three-drug combination has shown in a phase 1/2 clinical trial that it is a

JAK2 inhibitor demonstrates effective, durable control of myelofibrosis
A first-in-its class oral medication provides significant and durable relief for patients with a rare, debilitating and lethal bone marrow disorder called myelofibrosis, researchers at the University of Texas M.

New research demonstrates advances in optimizing treatments and quality of life
Research presented today at the 51st Annual Meeting of the American Society of Hematology explores optimal induction therapies for managing multiple myeloma, the importance of advance care planning for improved quality of life, and a potential new first-line therapy for patients with non-Hodgkin lymphoma.

Innovative strategies improve outcomes and prevent complications of stem cell transplants
The methods and outcomes for stem cell transplants are constantly improving as leading experts continue to investigate new approaches for reducing the serious adverse events associated with the procedure.

Mayo Clinic and collaborators find vitamin D levels associated with survival in lymphoma patients
A new study has found that the amount of vitamin D in patients being treated for diffuse large B-cell lymphoma was strongly associated with cancer progression and overall survival.

Donald Steiner named 2009 recipient of major international diabetes prize
Donald F. Steiner, M.D., Professor Emeritus at the University of Chicago, has been awarded the Manpei Suzuki Diabetes Prize for 2009, the largest award for diabetes research. is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to